Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$91.75

-1.44 (-1.55%)

09:55
08/15/18
08/15
09:55
08/15/18
09:55

Alnylam management to hold 8th annual RNAi Roundtable

Management holds its 8th Annual RNAi Roundtable on August 15 at 10:30 am.

  • 15

    Aug

  • 25

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 11

    Sep

ALNY Alnylam
$91.75

-1.44 (-1.55%)

08/13/18
NOMU
08/13/18
NO CHANGE
Target $73
NOMU
Reduce
Alnylam price target lowered to $73 from $86 at Nomura Instinet
Nomura Instinet analyst Christopher Marai lowered his price target for Alnylam Pharmaceuticals (ALNY) to $73 after the FDA approvaed FDA approved Onpattro for adult polyneuropathy of hereditary transthyretin-mediated amyloidosis, but not with cardiomyopathy. The "narrow label suggests significant headwind in securing market-share" before Pfizer's (PFE) tafamidis hits the market in the U.S., likely in 2019, Marai tells investors in a research note. The analyst keeps Reduce rating on Alnylam.
08/13/18
MSCO
08/13/18
NO CHANGE
Target $93
MSCO
Equal Weight
Alnylam price target cut to $93 from $99 at Morgan Stanley
Morgan Stanley analyst David Lebowitz lowered his price target for Alnylam Pharmaceuticals to $93 after Onpattro was approved by the FDA with a narrower label than anticipated by the Street, limiting therapy to hATTR-polyneuropathy patients, rather than indicating the drug for the broad hereditary TTR amyloidosis population as sought by management. The analyst keeps an Equal Weight rating on Alnylam.
08/13/18
08/13/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Rite Aid (RAD) downgraded to Market Perform from Outperform at Cowen with analyst Charles Rhyee saying shares of Ride Aid adequately reflect its outlook, following the termination of the company's merger with Albertsons. 2. Akamai (AKAM) downgraded to Neutral from Outperform at Credit Suisse with analyst Brad Zelnick saying with the stock up 29% since Elliott Management's disclosure of a stake on December 15, 2017, many of the catalysts have played out. 3. Alnylam (ALNY) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Terence Flynn saying the lack of cardio data in the approved U.S. label for Onpattro is disappointing and could represent a disadvantage versus Pfizer's (PFE) competitor drug Tafamadis. 4. Goodyear Tire (GT) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Armintas Sinkevicius saying he remains "constructive" on the long-term growth for global miles traveled, but believes this will not affect the stock for the next 12 months due to the overhang from estimate achievability. 5. Dish (DISH) downgraded to Sell from Neutral at MoffettNathanson with analyst Craig Moffett saying while the reported Q2 business conditions in the core satellite TV business were "genuinely better" amid reduced churn and slower subscriber losses, the Spectrum segment -- which holds "all" of the company's equity value -- is worse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/13/18
08/13/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GOLDMAN SACHS CUTS ALNYLAM TO BUY: Goldman Sachs analyst Terence Flynn downgraded Alnylam (ALNY) to Buy from Conviction Buy. The analyst also lowered his price target for the shares to $155 from $193. Flynn said the lack of cardio data in the approved U.S. label for Onpattro is disappointing and could represent a disadvantage versus Pfizer's (PFE) competitor drug Tafamadis. Piper Jaffray analyst Edward Tenthoff recommended buying shares of Alnylam Pharmaceuticals on weakness following the approval of Onpattro. Morgan Stanley analyst David Lebowitz lowered his price target to $93, Nomura Instinet analyst Christopher Marai lowered his price target to $73, and Stifel analyst Paul Matteis maintained a Buy rating but cut his price target to $123 from $125 and slightly lowered his revenue ramp for the drug based on modestly reduced share in mixed-phenotype haTTR patients and lower share in cardiac-only haTTR patients. B. Riley FBR analyst Madhu Kumar raised his price target to $230. RUBIUS THERAPEUTICS INITIATED AT MULTIPLE FIRMS: Rubius Therapeutics (RUBY) was initiated with an Outperform at Leerink, an Overweight at JPMorgan and Morgan Stanley, as well as a Buy at Jefferies. PIPER JAFFRAY SAYS AMAZON AD BUSINESS GROWING INTO PROFIT DRIVER: Amazon's (AMZN) advertising business "has been quietly growing into a massive driver of current and future profitability," Piper Jaffray analyst Michael Olson told investors in a research note. Applying an advertising comp multiple of 16 times to estimated 2020 Amazon advertising operating income suggests an ad business that should be valued at $150B-$190B, Olson contended. IMPERIAL CAPITAL CUTS NETFLIX PRICE TARGET TO $494: Imperial Capital analyst David Miller lowered his price target for Netflix (NFLX) to $494 after he slightly reduced his global subscriber estimates. The analyst said that in the "interest of being conservative," he decreased his fiscal 2018 global subscriber estimate to 141.2M from 141.4M and fiscal 2019 global subscriber estimate to 164.4M from 166.3M. DISH DOWNGRADED TO SELL AT MOFFETTNATHANSON: MoffettNathanson analyst Craig Moffett downgraded Dish (DISH) to Sell from Neutral with a price target of $29 and noted that while the reported Q2 business conditions in the core satellite TV business were "genuinely better" amid reduced churn and slower subscriber losses, the Spectrum segment -- which holds "all" of the company's equity value -- is worse.

TODAY'S FREE FLY STORIES

ATOM

Atomera

$3.29

(0.00%)

10:54
12/13/18
12/13
10:54
12/13/18
10:54
Conference/Events
Atomera participates in a conference call with Loop Capital »

Technology Analyst Acree…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOP

SPDR Oil Exploration and Production Fund

$30.55

-0.09 (-0.29%)

10:50
12/13/18
12/13
10:50
12/13/18
10:50
Options
Puts lead calls 5:1 in Oil Exploration ETF on large spread trades »

Puts lead calls 5:1 in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:50
12/13/18
12/13
10:50
12/13/18
10:50
General news
Action Alert: feel the pain. China's foreign direct investment plunged 26.3% y/y »

Action Alert: feel the…

10:45
12/13/18
12/13
10:45
12/13/18
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

10:45
12/13/18
12/13
10:45
12/13/18
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

BABA

Alibaba

$152.98

1.49 (0.98%)

, TAP

Molson Coors

$63.34

0.33 (0.52%)

10:42
12/13/18
12/13
10:42
12/13/18
10:42
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

BABA

Alibaba

$152.98

1.49 (0.98%)

TAP

Molson Coors

$63.34

0.33 (0.52%)

KDP

Keurig Dr Pepper

$26.21

0.1 (0.38%)

PEP

PepsiCo

$118.32

1.34 (1.15%)

STZ

Constellation Brands

$182.75

-3.95 (-2.12%)

MNST

Monster Beverage

$54.59

-2.855 (-4.97%)

SAM

Boston Beer

$262.13

-11.95 (-4.36%)

SPNE

SeaSpine

$17.04

-0.12 (-0.70%)

XPO

XPO Logistics

$55.02

-5.23 (-8.68%)

ENTA

Enanta

$74.62

0.06 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Feb

  • 04

    Mar

KO

Coca-Cola

$49.28

0.08 (0.16%)

, FEYE

FireEye

$18.53

-0.99 (-5.07%)

10:42
12/13/18
12/13
10:42
12/13/18
10:42
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

KO

Coca-Cola

$49.28

0.08 (0.16%)

FEYE

FireEye

$18.53

-0.99 (-5.07%)

SABR

Sabre

$24.30

-0.7 (-2.80%)

WFT

Weatherford

$0.45

-0.0211 (-4.52%)

ARGO

Argo Group

$68.24

-0.18 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 18

    Dec

  • 18

    Dec

  • 09

    Jan

  • 10

    Jan

  • 03

    Mar

  • 04

    Mar

GE

General Electric

$7.45

0.725 (10.79%)

, FIVE

Five Below

$102.00

0.62 (0.61%)

10:42
12/13/18
12/13
10:42
12/13/18
10:42
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

GE

General Electric

$7.45

0.725 (10.79%)

FIVE

Five Below

$102.00

0.62 (0.61%)

TSCO

Tractor Supply

$92.46

0.72 (0.78%)

PG

Procter & Gamble

$96.43

2.4 (2.55%)

DY

Dycom

$58.43

1.79 (3.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

GME

GameStop

$12.83

-0.405 (-3.06%)

10:40
12/13/18
12/13
10:40
12/13/18
10:40
Options
At-the-money put buyer in GameStop »

At-the-money put buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:34
12/13/18
12/13
10:34
12/13/18
10:34
General news
EIA natural gas storage change for week ending December 7 »

Gas inventories 77 Bcf…

CCJ

Cameco

$12.21

0.18 (1.50%)

10:30
12/13/18
12/13
10:30
12/13/18
10:30
Options
Call buyers and put sellers in Cameco »

Call buyers and put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEUM

Pareteum

$1.68

0.02 (1.20%)

10:29
12/13/18
12/13
10:29
12/13/18
10:29
Conference/Events
Pareteum management to meet with Lake Street »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

TCO

Taubman Centers

$52.24

1.86 (3.69%)

10:28
12/13/18
12/13
10:28
12/13/18
10:28
Conference/Events
Taubman Centers management to meet with KeyBanc »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

SQ

Square

$63.47

-0.2 (-0.31%)

10:27
12/13/18
12/13
10:27
12/13/18
10:27
Conference/Events
Square management to meet with Wedbush »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

  • 18

    Dec

UAA

Under Armour

$19.48

-0.33 (-1.67%)

, UA

Under Armour

$18.38

-0.62 (-3.26%)

10:25
12/13/18
12/13
10:25
12/13/18
10:25
Hot Stocks
Under Armour CEO says reaction from attendees at investor day was positive »

Under Armour CEO Kevin…

UAA

Under Armour

$19.48

-0.33 (-1.67%)

UA

Under Armour

$18.38

-0.62 (-3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 03

    Mar

10:25
12/13/18
12/13
10:25
12/13/18
10:25
General news
Today's U.S. reports »

Today's U.S. reports…

10:21
12/13/18
12/13
10:21
12/13/18
10:21
Conference/Events
JPMorgan Internet analyst to hold an analyst/industry conference call »

Internet Analyst Anmuth…

10:19
12/13/18
12/13
10:19
12/13/18
10:19
Conference/Events
JPMorgan household/personal care analysts hold analyst/industry conference call »

Household & Personal…

SMTC

Semtech

$48.38

0.14 (0.29%)

10:17
12/13/18
12/13
10:17
12/13/18
10:17
Conference/Events
Semtech management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/13/18
12/13
10:17
12/13/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$7.38

0.66 (9.82%)

10:16
12/13/18
12/13
10:16
12/13/18
10:16
On The Fly
General Electric jumps as long-time bear ups rating after two and a half years »

Shares of General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAIA

Saia

$55.48

0.175 (0.32%)

10:16
12/13/18
12/13
10:16
12/13/18
10:16
Conference/Events
Saia management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 20

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/13/18
12/13
10:16
12/13/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGI

Alamos Gold

$3.22

-0.19 (-5.57%)

10:15
12/13/18
12/13
10:15
12/13/18
10:15
Downgrade
Alamos Gold rating change  »

Alamos Gold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
12/13/18
12/13
10:15
12/13/18
10:15
General news
Breaking General news story  »

Week of 12/7 EIA Natural…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.